Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
92 GBX | -5.64% | -12.38% | +36.30% |
Mar. 25 | Feedback shares skyrocket on partnership for TB screening in India | AN |
Mar. 25 | Feedback plc, Heal Foundation Team Up for Tuberculosis Screening Projects in India | MT |
Strengths
- The prospective high growth for the next fiscal years is among the main assets of the company
- Thanks to a sound financial situation, the firm has significant leeway for investment.
- Analysts have a positive opinion on this stock. Average consensus recommends overweighting or purchasing the stock.
- The average target price set by analysts covering the stock is above current prices and offers a tremendous appreciation potential.
Weaknesses
- The company's profitability before interest, taxes, depreciation and amortization characterizes fragile margins.
- The company's "enterprise value to sales" ratio is among the highest in the world.
Ratings chart - Surperformance
Sector: Advanced Medical Equipment & Technology
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
+36.30% | 16.19M | - | ||
+4.97% | 32.47B | C | ||
+16.51% | 7.45B | C- | ||
+22.16% | 3.89B | B- | ||
-15.89% | 3.17B | C- | ||
-27.11% | 1.28B | B | ||
-36.14% | 1.09B | - | ||
-35.42% | 902M | - | ||
+0.72% | 893M | C | ||
-26.12% | 857M | - | C+ |
Financials
Valuation
Momentum
Consensus
Business Predictability
Technical analysis
- Stock Market
- Equities
- FDBK Stock
- Ratings Feedback plc